276 related articles for article (PubMed ID: 20493927)
1. Multi-stage delivery nano-particle systems for therapeutic applications.
Serda RE; Godin B; Blanco E; Chiappini C; Ferrari M
Biochim Biophys Acta; 2011 Mar; 1810(3):317-29. PubMed ID: 20493927
[TBL] [Abstract][Full Text] [Related]
2. Mitotic trafficking of silicon microparticles.
Serda RE; Ferrati S; Godin B; Tasciotti E; Liu X; Ferrari M
Nanoscale; 2009 Nov; 1(2):250-9. PubMed ID: 20644846
[TBL] [Abstract][Full Text] [Related]
3. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics.
Martinez JO; Chiappini C; Ziemys A; Faust AM; Kojic M; Liu X; Ferrari M; Tasciotti E
Biomaterials; 2013 Nov; 34(33):8469-77. PubMed ID: 23911070
[TBL] [Abstract][Full Text] [Related]
4. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics.
Godin B; Tasciotti E; Liu X; Serda RE; Ferrari M
Acc Chem Res; 2011 Oct; 44(10):979-89. PubMed ID: 21902173
[TBL] [Abstract][Full Text] [Related]
5. Cellular association and assembly of a multistage delivery system.
Serda RE; Mack A; Pulikkathara M; Zaske AM; Chiappini C; Fakhoury JR; Webb D; Godin B; Conyers JL; Liu XW; Bankson JA; Ferrari M
Small; 2010 Jun; 6(12):1329-40. PubMed ID: 20517877
[TBL] [Abstract][Full Text] [Related]
6. Intracellular trafficking of silicon particles and logic-embedded vectors.
Ferrati S; Mack A; Chiappini C; Liu X; Bean AJ; Ferrari M; Serda RE
Nanoscale; 2010 Aug; 2(8):1512-20. PubMed ID: 20820744
[TBL] [Abstract][Full Text] [Related]
7. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.
Serda RE; Gu J; Bhavane RC; Liu X; Chiappini C; Decuzzi P; Ferrari M
Biomaterials; 2009 May; 30(13):2440-8. PubMed ID: 19215978
[TBL] [Abstract][Full Text] [Related]
8. Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.
Godin B; Chiappini C; Srinivasan S; Alexander JF; Yokoi K; Ferrari M; Decuzzi P; Liu X
Adv Funct Mater; 2012 Oct; 22(20):4225-4235. PubMed ID: 23227000
[TBL] [Abstract][Full Text] [Related]
9. Tailored porous silicon microparticles: fabrication and properties.
Chiappini C; Tasciotti E; Fakhoury JR; Fine D; Pullan L; Wang YC; Fu L; Liu X; Ferrari M
Chemphyschem; 2010 Apr; 11(5):1029-35. PubMed ID: 20162656
[TBL] [Abstract][Full Text] [Related]
10. Porous silicon advances in drug delivery and immunotherapy.
Savage DJ; Liu X; Curley SA; Ferrari M; Serda RE
Curr Opin Pharmacol; 2013 Oct; 13(5):834-41. PubMed ID: 23845260
[TBL] [Abstract][Full Text] [Related]
11. Dual-Action Cancer Therapy with Targeted Porous Silicon Nanovectors.
Cifuentes-Rius A; Ivask A; Sporleder E; Kaur I; Assan Y; Rao S; Warther D; Prestidge CA; Durand JO; Voelcker NH
Small; 2017 Aug; 13(29):. PubMed ID: 28570785
[TBL] [Abstract][Full Text] [Related]
12. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
[TBL] [Abstract][Full Text] [Related]
13. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows.
Gentile F; Chiappini C; Fine D; Bhavane RC; Peluccio MS; Cheng MM; Liu X; Ferrari M; Decuzzi P
J Biomech; 2008 Jul; 41(10):2312-8. PubMed ID: 18571181
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterials in cancer-therapy drug delivery system.
Zhang G; Zeng X; Li P
J Biomed Nanotechnol; 2013 May; 9(5):741-50. PubMed ID: 23802404
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles.
Serda RE; Blanco E; Mack A; Stafford SJ; Amra S; Li Q; van de Ven A; Tanaka T; Torchilin VP; Wiktorowicz JE; Ferrari M
Mol Imaging; 2011 Feb; 10(1):43-55. PubMed ID: 21303614
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
[TBL] [Abstract][Full Text] [Related]
17. Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads.
Gu L; Park JH; Duong KH; Ruoslahti E; Sailor MJ
Small; 2010 Nov; 6(22):2546-52. PubMed ID: 20814923
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured porous silicon-mediated drug delivery.
Martín-Palma RJ; Hernández-Montelongo J; Torres-Costa V; Manso-Silván M; Muñoz-Noval Á
Expert Opin Drug Deliv; 2014 Aug; 11(8):1273-83. PubMed ID: 24941438
[TBL] [Abstract][Full Text] [Related]
19. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.
Tölli MA; Ferreira MP; Kinnunen SM; Rysä J; Mäkilä EM; Szabó Z; Serpi RE; Ohukainen PJ; Välimäki MJ; Correia AM; Salonen JJ; Hirvonen JT; Ruskoaho HJ; Santos HA
Biomaterials; 2014 Sep; 35(29):8394-405. PubMed ID: 24985734
[TBL] [Abstract][Full Text] [Related]
20. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
